Skip to main content
Top
Published in: Familial Cancer 1/2021

Open Access 01-01-2021 | Breast Cancer | Original Article

Improving primary care identification of familial breast cancer risk using proactive invitation and decision support

Authors: Nadeem Qureshi, Brittany Dutton, Stephen Weng, Christina Sheehan, Wendy Chorley, John F. R. Robertson, Denise Kendrick, Joe Kai

Published in: Familial Cancer | Issue 1/2021

Login to get access

Abstract

Family history of breast cancer is a key risk factor, accounting for up to 10% of cancers. We evaluated the proactive assessment of familial breast cancer (FBC) risk in primary care. Eligible women (30 to 60 years) were recruited from eight English general practices. Practices were trained on FBC risk assessment. In four randomly-assigned practices, women were invited to complete a validated, postal family history questionnaire, which practice staff inputted into decision support software to determine cancer risk. Those with increased risk were offered specialist referral. Usual care was observed in the other four practices. In intervention practices, 1127/7012 women (16.1%) returned family history questionnaires, comprising 1105 (98%) self-reported white ethnicity and 446 (39.6%) educated to University undergraduate or equivalent qualification, with 119 (10.6%) identified at increased breast cancer risk and offered referral. Sixty-seven (56%) women recommended referral were less than 50 years old. From 66 women attending specialists, 26 (39.4%) were confirmed to have high risk and recommended annual surveillance (40–60 years) and surgical prevention; while 30 (45.5%) were confirmed at moderate risk, with 19 offered annual surveillance (40–50 years). The remaining 10 (15.2%) managed in primary care. None were recommended chemoprevention. In usual care practices, only ten women consulted with concerns about breast cancer family history. This study demonstrated proactive risk assessment in primary care enables accurate identification of women, including many younger women, at increased risk of breast cancer. To improve generalisability across the population, more active methods of engagement need to be explored.
Trial registration: CRUK Clinical Trials Database 11779.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman N, Krishnan S, Sullivan R, Kombe D, Blas MM, Parham G, Kassami N, Conteh L (2017) The global burden of women’s cancers: a grand challenge in global health. Lancet 10071:847–860. https://doi.org/10.1016/S0140-6736(16)31392-7CrossRef Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, Sarker M, Huong TT, Allemani C, Dvaladze A, Gralow J, Yeates K, Taylor C, Oomman N, Krishnan S, Sullivan R, Kombe D, Blas MM, Parham G, Kassami N, Conteh L (2017) The global burden of women’s cancers: a grand challenge in global health. Lancet 10071:847–860. https://​doi.​org/​10.​1016/​S0140-6736(16)31392-7CrossRef
9.
go back to reference Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 9:1384–1392. https://doi.org/10.1038/bjc.2011.120CrossRef Metcalfe K, Gershman S, Lynch HT, Ghadirian P, Tung N, Kim-Sing C, Olopade OI, Domchek S, McLennan J, Eisen A, Foulkes WD, Rosen B, Sun P, Narod SA (2011) Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer 9:1384–1392. https://​doi.​org/​10.​1038/​bjc.​2011.​120CrossRef
15.
go back to reference Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ (2009) Developing family healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6(1):A33PubMed Yoon PW, Scheuner MT, Jorgensen C, Khoury MJ (2009) Developing family healthware, a family history screening tool to prevent common chronic diseases. Prev Chronic Dis 6(1):A33PubMed
16.
go back to reference Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A (2014) Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res 10:993–1001. https://doi.org/10.1158/1940-6207.capr-14-0037CrossRef Evans DG, Brentnall AR, Harvie M, Dawe S, Sergeant JC, Stavrinos P, Astley S, Wilson M, Ainsworth J, Cuzick J, Buchan I, Donnelly LS, Howell A (2014) Breast cancer risk in young women in the national breast screening programme: implications for applying NICE guidelines for additional screening and chemoprevention. Cancer Prev Res 10:993–1001. https://​doi.​org/​10.​1158/​1940-6207.​capr-14-0037CrossRef
17.
go back to reference Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L, Gentilini O, Peccatori F, Fourquet A, Delaloge S, Marotti L, Penault-Llorca F, Kotti-Kitromilidou AM, Rodger A, Harbeck N (2012) The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 18:3355–3377. https://doi.org/10.1016/j.ejca.2012.10.004CrossRef Cardoso F, Loibl S, Pagani O, Graziottin A, Panizza P, Martincich L, Gentilini O, Peccatori F, Fourquet A, Delaloge S, Marotti L, Penault-Llorca F, Kotti-Kitromilidou AM, Rodger A, Harbeck N (2012) The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer 18:3355–3377. https://​doi.​org/​10.​1016/​j.​ejca.​2012.​10.​004CrossRef
18.
go back to reference Zonderland HM, Tuut MK, den Heeten GJ, Asperen CJ, de Bock GH, Rutqers EJ, Westenend PJ, Smit GM, Benraadt J (2008) Eur J Cancer 152:2336–2339 Zonderland HM, Tuut MK, den Heeten GJ, Asperen CJ, de Bock GH, Rutqers EJ, Westenend PJ, Smit GM, Benraadt J (2008) Eur J Cancer 152:2336–2339
19.
go back to reference Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Natl Cancer Inst 21:1633–1637. https://doi.org/10.1093/jnci/93.21.1633CrossRef Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Vockley CW, Deffenbaugh A, Couch FJ, Jenkins RB (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Natl Cancer Inst 21:1633–1637. https://​doi.​org/​10.​1093/​jnci/​93.​21.​1633CrossRef
20.
go back to reference Evans DGR, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HFA, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A (2009) Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet 46:254–258. https://doi.org/10.1136/jmg.2008.062232CrossRefPubMed Evans DGR, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HFA, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A (2009) Risk reducing mastectomy: outcomes in 10 European centres. J Med Genet 46:254–258. https://​doi.​org/​10.​1136/​jmg.​2008.​062232CrossRefPubMed
21.
go back to reference Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 5:427–437CrossRef Kriege M, Brekelmans CT, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM, Manoliu RA, Kok T, Peterse H, Tilanus-Linthorst MM (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 5:427–437CrossRef
22.
go back to reference FH01 (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 12:1127–1134 FH01 (2010) Mammographic surveillance in women younger than 50 years who have a family history of breast cancer: tumour characteristics and projected effect on mortality in the prospective, single-arm, FH01 study. Lancet Oncol 12:1127–1134
25.
go back to reference Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 9922:1041–1048. https://doi.org/10.1016/s0140-6736(13)62292-8CrossRef Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A (2014) Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. Lancet 9922:1041–1048. https://​doi.​org/​10.​1016/​s0140-6736(13)62292-8CrossRef
26.
go back to reference Schunemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nystrom L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Grawingholt A, Saz-Parkinson Z (2019) Breast cancer screening and diagnosis: a synopsis of the european breast guidelines. Ann Intern Med 172:46–56. https://doi.org/10.7326/m19-2125CrossRefPubMed Schunemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, Lebeau A, Nystrom L, Broeders M, Ioannidou-Mouzaka L, Duffy SW, Borisch B, Fitzpatrick P, Hofvind S, Castells X, Giordano L, Canelo-Aybar C, Warman S, Mansel R, Sardanelli F, Parmelli E, Grawingholt A, Saz-Parkinson Z (2019) Breast cancer screening and diagnosis: a synopsis of the european breast guidelines. Ann Intern Med 172:46–56. https://​doi.​org/​10.​7326/​m19-2125CrossRefPubMed
29.
go back to reference Qureshi N, O’Flynn N, Evans G (2014) Dealing with family history of breast cancer: something new, something old. Br J Gen Pract. 64(618):6–7CrossRef Qureshi N, O’Flynn N, Evans G (2014) Dealing with family history of breast cancer: something new, something old. Br J Gen Pract. 64(618):6–7CrossRef
30.
go back to reference Nippert I, Julian-Reynier C, Harris H, Evans G, van Asperen CJ, Tibben A, Schmidtke J (2014) Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet 1:69–79. https://doi.org/10.1007/s12687-013-0173-xCrossRef Nippert I, Julian-Reynier C, Harris H, Evans G, van Asperen CJ, Tibben A, Schmidtke J (2014) Cancer risk communication, predictive testing and management in France, Germany, the Netherlands and the UK: general practitioners' and breast surgeons' current practice and preferred practice responsibilities. J Community Genet 1:69–79. https://​doi.​org/​10.​1007/​s12687-013-0173-xCrossRef
35.
go back to reference Qureshi N, Bethea J, Modell B, Brennan P, Papageorgiou A, Raeburn S, Hapgood R, Modell M (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 6:663–669CrossRef Qureshi N, Bethea J, Modell B, Brennan P, Papageorgiou A, Raeburn S, Hapgood R, Modell M (2005) Collecting genetic information in primary care: evaluating a new family history tool. Fam Pract 6:663–669CrossRef
38.
go back to reference Scheuner MT, Hamilton AB, Peredo J, Sale TJ, Austin C, Gilman SC, Bowen MS, Goldzweig CL, Lee M, Mittman BS, Yano EM (2014) A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet Med 1:60–69. https://doi.org/10.1038/gim.2013.75CrossRef Scheuner MT, Hamilton AB, Peredo J, Sale TJ, Austin C, Gilman SC, Bowen MS, Goldzweig CL, Lee M, Mittman BS, Yano EM (2014) A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians. Genet Med 1:60–69. https://​doi.​org/​10.​1038/​gim.​2013.​75CrossRef
Metadata
Title
Improving primary care identification of familial breast cancer risk using proactive invitation and decision support
Authors
Nadeem Qureshi
Brittany Dutton
Stephen Weng
Christina Sheehan
Wendy Chorley
John F. R. Robertson
Denise Kendrick
Joe Kai
Publication date
01-01-2021
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 1/2021
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-020-00188-z

Other articles of this Issue 1/2021

Familial Cancer 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine